logo

For the Inventor, By the Inventor

Somerset, NJ, United States of America

Robert E McDevitt

This inventor holds 24 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Wyeth, American Home Products Corporation, Other. Active years: 2000-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert E McDevitt. Retrieved from https://idiyas.com/inventor/robert-e-mcdevitt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24

% Patents Active = 29.2

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 187(Granted Patents)


Location History:

  • Somerset, NJ (US) (2000 - 2009)
  • Freehold, NJ (US) (2010)

Company Filing History:

goldMedal15 out of 1,309 
 
Wyeth
 patents
silverMedal8 out of 1,567 
 
American Home Products Corporation
 patents
bronzeMedal1 out of 834,601 
Other
 patents

Years Active: 2000-2010

Loading Chart...
Areas of Expertise:
Insulin Resistance
Smooth Muscle Cell Proliferation
Estrogenic Agents
Biphenyls
Furans
Benzofurans
Thiophenes
Ligands
Derivatives
Antipsychotic Agents
Hyperglycemia
Inhibitors
24 patents (USPTO):Explore Patents
1. 7723329 - Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands (2010-05-25),
2. 7645752 - Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors (2010-01-12),
3. 7531564 - Substituted benzoxazoles as estrogenic agents (2009-05-12),
4. 7514411 - Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation (2009-04-07),
5. 7148247 - Substituted benzoxazoles as estrogenic agents (2006-12-12),
6. 7132402 - Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation (2006-11-07),
7. 7129258 - Substituted benzoxazoles as estrogenic agents (2006-10-31),
8. 7071185 - 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents (2006-07-04),
9. 7008636 - 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia (2006-03-07),
10. 6903238 - Substituted indenones as estrogenic agents (2005-06-07),
11. 6794403 - Substituted benzoxazoles as estrogenic agents (2004-09-21),
12. 6765021 - 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia (2004-07-20),
13. 6683107 - Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia (2004-01-27),
14. 6451845 - Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia (2002-09-17),
15. 6451827 - 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia (2002-09-17),

Title: The Inventor Robert E McDevitt: Pioneering Innovations in Somerset

Introduction: Robert E McDevitt is a distinguished inventor based in Somerset, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Robert E McDevitt holds several patents in cutting-edge technologies related to renewable energy, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Robert E McDevitt has worked tirelessly to bring his visionary ideas to life, revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Robert E McDevitt has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions, showcasing his ability to work across diverse teams.

Conclusion: Robert E McDevitt's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions, leaving a lasting impact on the industry and society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…